Xtant Medical Holdings (XTNT) Price Target Decreased by 10.00% to 1.38

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks XTNT Xtant Medical Holdings (XTNT) Price Target Decreased by 10.00% to 1.38 March 27, 2026 — 11:03 pm EDT Written by George Maybach for Fintel-> The average one-year price target for Xtant Medical Holdings (NYSEAM:XTNT) has been revised to $1.38 / share. This is a decrease of 10.00% from the prior estimate of $1.53 dated February 21, 2026. The price target is an average of many targets provided by analysts. The latest targets range from a low of $1.21 to a high of $1.58 / share. The average price target represents an increase of 157.67% from the latest reported closing price of $0.53 / share. What is the Fund Sentiment? There are 38 funds or institutions reporting positions in Xtant Medical Holdings. This is an decrease of 1 owner(s) or 2.56% in the last quarter. Average portfolio weight of all funds dedicated to XTNT is 0.01%, an increase of 83.65%. Total shares owned by institutions increased in the last three months by 0.86% to 81,405K shares. What are Other Shareholders Doing?

Nantahala Capital Management holds 68,394K shares representing 48.85% ownership of the company. No change in the last quarter. AWM Investment holds 6,594K shares representing 4.71% ownership of the company. No change in the last quarter. Renaissance Technologies holds 920K shares representing 0.66% ownership of the company. In its prior filing, the firm reported owning 714K shares , representing an increase of 22.39%.

Geode Capital Management holds 492K shares representing 0.35% ownership of the company. No change in the last quarter.

Crescent Grove Advisors holds 412K shares representing 0.29% ownership of the company. No change in the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.Click to Learn MoreThis story originally appeared on Fintel. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags Stocks Fintel Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford. Check out our Unique Analysis of Insider Sentiment for Xtant Medical Holdings, Inc.-> Find out what the Options Markets think of Xtant Medical Holdings, Inc.-> See our take on Xtant Medical Holdings, Inc. Upcoming Earnings-> More articles by this source-> Stocks mentioned XTNT More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.